Metformin is a standard clinical drug used to treat type 2 diabetes mellitus (T2DM) and
polycystic ovary syndrome. Recently, epidemiological studies and meta‑analyses have …

Patients with diabetes mellitus are at increased risk of cancer development. Metformin is a
well-established, effective agent for the management of type 2 diabetes mellitus …

Small‑molecule chemical drugs are of great significance for tumor‑targeted and
individualized therapies. However, the development of new small‑molecule drugs, from …

Metformin is considered, in conjunction with lifestyle modification, as a first-line treatment
modality for type 2 diabetes mellitus (DM). Recently, several clinical studies have reported …

Metformin is widely used in the treatment of diabetes mellitus type 2 where it reduces insulin
resistance and diabetes-related morbidity and mortality. Population-based studies show that …

Metformin, a biguanide derivative that is widely used for treating type 2 diabetes mellitus,
has recently been shown to exert potential anticancer effects. Many retrospective data and …

Since epidemiologic data have highlighted the positive effects of metformin to reduce cancer
incidence and mortality, many in vitro and in vivo studies as well as a large number of …

Metformin, one of most widely prescribed oral hypoglycemic agents, has recently received
increased attention because of its potential antitumorigenic effects that are thought to be …

Metformin and cancer therapy : Current Opinion in Oncology Metformin and cancer therapy :
Current Opinion in Oncology Log in or Register Subscribe to journalSubscribe Get new issue …

Laboratory research and pharmacoepidemiology are providing converging evidence that
the widely used antidiabetic drug metformin has antineoplastic activity, but there are …